Stem Cell Therapy for Osteoarthritis
Regenerative Relief: Stem Cell Therapy for Osteoarthritis
Stem cell therapy for osteoarthritis is a non-surgical, regenerative treatment that focuses on restoring joint health by targeting the root cause of inflammation and cartilage degeneration. By using mesenchymal stem cells (MSCs), this therapy stimulates healing, reduces pain, and improves joint function for those suffering from knee, hip, shoulder, and other joint-related osteoarthritis. Learn more about mesenchymal stem cells on Wikipedia.
With an increasing demand for long-term solutions beyond steroids or invasive surgery, stem cell therapy for osteoarthritis offers a powerful option to support natural regeneration and delay or eliminate the need for joint replacement.
Key Benefits of Stem Cell Therapy for Osteoarthritis
- May reduce chronic joint inflammation
- Supports natural cartilage repair and joint regeneration
- May reduce stiffness, swelling, and grinding pain
- No general anesthesia or overnight hospital stay required
- Compatible with physiotherapy and rehab programs
- May delay or eliminate the need for total joint replacement
Our in-person consultations include clinical evaluation and imaging to determine candidacy.
International patients can begin with a remote assessment. Our specialists will evaluate your medical history, imaging, and symptoms.
We tailor your stem cell therapy for osteoarthritis based on your age, severity, goals, and physical condition.
+1 888-471-3341
Our Value
Why Choose Stem Cell Therapy for Osteoarthritis in Mexico?
We combine advanced biological treatments with personalized patient care in Cancun—offering both comfort and clinical excellence.
Common Questions
Frequently Asked Questions About Stem Cell Therapy for Osteoarthritis
Stem cell therapy for osteoarthritis involves injecting mesenchymal stem cells (MSCs) directly into the affected joint. These powerful cells have the potential to reduce inflammation, repair damaged cartilage, and regenerate joint tissue. MSCs are sourced from umbilical cord tissue and are known for their ability to modulate immune response and support healing. Learn more about MSCs on Wikipedia.
Most patients begin to feel relief within 4 to 8 weeks. However, improvements in joint mobility, pain, and function often continue to develop over 3 to 6 months. The regenerative nature of the therapy means it works gradually to rebuild tissue and reduce inflammation.
Typically, only one session of stem cell therapy is needed for mild to moderate osteoarthritis. More advanced cases may benefit from a follow-up injection after several months. Treatment plans are tailored to individual patient needs and joint condition.
The procedure is minimally invasive and involves a simple injection guided by ultrasound. A local anesthetic is used to ensure comfort. Patients usually report mild soreness for a day or two but can return to normal activity quickly.
Prices generally range from $2,500 to $6,500 USD, depending on the number of joints treated and the complexity of the protocol. This is significantly lower than comparable treatment costs in the U.S., where similar regenerative therapies may exceed $10,000.
We use umbilical cord-derived mesenchymal stem cells sourced from certified laboratories. These cells are free from ethical controversy and are screened rigorously to ensure safety and potency.
Yes. While it may not fully restore lost cartilage in severe cases, stem cell therapy can reduce inflammation, ease pain, and potentially slow down further joint deterioration. For some, it can delay the need for total joint replacement.
Stem cell therapy is generally safe and well-tolerated. Minor side effects may include swelling, soreness, or temporary discomfort at the injection site. Serious adverse effects are extremely rare when performed under medical supervision.
Stem cell therapy for osteoarthritis remains classified as experimental in the U.S. However, international clinics like Renova Therapies offer this treatment under approved, regulated guidelines. The global medical community continues to explore its full potential through ongoing research and trials.
Mexico provides access to advanced regenerative medicine at affordable rates. Patients benefit from high-quality care, experienced physicians, and no waitlists. It’s a safe, reputable destination for medical travel, offering therapies that may not yet be available or affordable in their home countries.
Yes, stem cell therapy has shown promise in improving joint health for individuals with diabetes or metabolic disorders. Since diabetes can impair circulation and slow down healing, mesenchymal stem cells may help reduce systemic inflammation and support localized joint recovery. Learn more from the WHO fact sheet on diabetes.